Search Results - "Decatris, M. P."

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    High-dose chemotherapy and autologous haematopoietic support in poor risk non-seminomatous germ-cell tumours: An effective first-line therapy with minimal toxicity by Decatris, M. P., Wilkinson, P. M., Welch, R. S., Metzner, M., Morgenstern, G. R., Dougall, M.

    Published in Annals of oncology (01-04-2000)
    “…Background: The prognosis of patients with high-risk germ-cell cancer is poor. The toxicity and efficacy of first-line high-dose chemotherapy (HDCT) with…”
    Get full text
    Journal Article
  2. 2

    Phase II trial of Oxaliplatin and 5-Fluorouracil/Leucovorin combination in epithelial ovarian carcinoma relapsing within 2 years of platinum-based therapy by Sundar, S, Symonds, R.P, Decatris, M.P, Kumar, D.M, Osman, A, Vasanthan, S, O'byrne, K.J

    Published in Gynecologic oncology (01-08-2004)
    “…Objective. To evaluate the efficacy and toxicity of Oxaliplatin and 5-Fluorouracil (5-FU)/Leucovorin (LV) combination in ovarian cancer relapsing within 2…”
    Get full text
    Journal Article
  3. 3

    Platinum-based chemotherapy in metastatic breast cancer: current status by Decatris, M.P, Sundar, S, O’Byrne, K.J

    Published in Cancer treatment reviews (01-02-2004)
    “…Cisplatin and carboplatin are active in previously untreated patients with metastatic breast cancer (MBC) with mean response rates (RRs) of 50 and 32%,…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Platinum-based Chemotherapy in Metastatic Breast Cancer: The Leicester (UK) Experience by Decatris, M.P., Sundar, S., O'Byrne, K.J.

    “…After failure of anthracycline- and taxane-based chemotherapy in metastatic breast cancer, treatment options until recently were limited. Until the…”
    Get full text
    Journal Article
  6. 6

    Reversibility of liver failure secondary to metastatic breast cancer by vinorelbine and cisplatin chemotherapy by SHARMA, Ricky A, DECATRIS, Marios P, SANTHANAM, Sundar, ROY, Rajarshi, OSMAN, Ahmed E, CLARKE, Christine B, KHANNA, Subhash, O'BYRNE, Kenneth J

    Published in Cancer chemotherapy and pharmacology (01-11-2003)
    “…The development of liver metastases from breast cancer is associated with a very poor prognosis, estimated at 4 months median survival. Since treatment with…”
    Get full text
    Journal Article